Please Wait...

Patient Reimbursement

Pay Your Clinical Trial Subjects Promptly and Digitally

Eliminate the need for sites to manually pay and account for subject payments and provide prepaid debit cards, allowing sites to compensate subjects quickly and efficiently through an online, automated application. Payments can be loaded onto subject debit cards with funds available for use in real-time.

With Bioclinica Patient Reimbursement, you can:

  • Eliminate the need for site accounting
  • Reduce costs and transactional fees
  • Make payments directly to subjects

Card is issued by The Bancorp Bank, Member FDIC, pursuant to a license from Visa U.S.A. Inc.

Download our PATIENT REIMBURSEMENT Data sheet

ADDITIONAL RESOURCES

Bioclinica PAYMENTS & FORECASTING Solutions Platform

Download Overview SHEET

PATIENT REIMBURSEMENT

Download DATA SHEET

6 Reasons Why You Should Choose Bioclinica's PAYMENTS & FORECASTING Solutions

Download Infographic

Challenges with Cash Management and Reforecasting Clinical Trials

Download eBook

ROI Initiative: A Technology Solution for Investigator Payments

Download eBook

Embracing Clinical Trial Technology

Download eBook

Competitive Advantages of Accelerating Payments to Investigative Sites

Download eBook

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (2 days ago)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen